Project Grant P30AG097142
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $372,904 to The University of Texas Health Science Center at San Antonio to advance cross-national research on aging and cognitive function. The 5-year grant, awarded on September 20, 2025, supports an annual program that recruits, trains, and mentors 16 post-graduate participants dedicated to mastering Down syndrome (DS) clinical research. The program offers hands-on DS clinical...
- This $310,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by Texas Tech University Health Sciences Center (TTUHSC) to examine how alternative polyadenylation (APA) of mRNAs contributes to the development and progression of Alzheimer's disease (AD). The project has two main goals: 1) to identify APA genes and pathways associated with AD pathology using computational analysis of existing single-cell RNA-sequencing datasets, and 2)...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $2,465,320 project grant to Arizona State University (ASU) to develop a performance-based measure of daily function for screening Hispanic/Latino older adults for Alzheimer's disease (AD) risk. The award period spans from Sep 15, 2025 to Sep 14, 2029. The goal is to leverage the existing MindCrowd electronic cohort to evaluate a newly developed, brief, and simple behavioral test (the...
- This federal Project Grant award for $2,557,260 from the National Institute on Aging (CFDA 93.866 Aging Research program) will fund a study titled "Lifecourse Predictors and Mechanisms of Early Clinical ADRD among Black and White Adults in their Sixties". The study aims to investigate the transition from midlife to early late-life and identify the earliest manifestations of Alzheimer's disease (AD) and Alzheimer's disease-related disorders (ADRD) in a diverse population. The research...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a $163,080 research project titled "Bridging Gaps to Translate Plasma Alzheimer's Disease Biomarkers to Diverse Populations." The project, led by the University of Texas Health Science Center at San Antonio, aims to address critical gaps in understanding the performance of plasma biomarkers for Alzheimer's disease and related dementias in diverse population cohorts, including in the...
- This federal Project Grant award, provided by the National Institute on Aging (CFDA 93.866 Aging Research), will establish the North Texas Alzheimer's Disease Research Center (NT-ADRC) to serve the North Texas region. The $4,663,946 award, with a project period from June 15, 2025 to March 31, 2030, will enable the University of Texas Southwestern Medical Center to build a multidisciplinary research center focused on examining the roles of hypertension and other cardiometabolic factors in the...
- The Project Grant titled "The Role of Neighborhood Social Exposome Dynamics in Risk and Resilience to Alzheimer's Disease and Related Dementias" was awarded by the National Institute on Aging (NIA), under CFDA Program 93.866 - Aging Research. The $3,039,714 grant, with a performance period from September 15, 2025 to September 14, 2029, will investigate the pathways between 30 years of neighborhood-level social exposome change, individual modifiable Alzheimer's disease and related...
- This federal Project Grant award of $372,690, provided by the National Institute on Aging (CFDA 93.866 Aging Research), aims to comprehensively understand the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The key objectives are to: (1) develop new statistical methods for uncovering heterogeneous causal relationships among amyloid-beta, tau accumulation, and cognition across diverse AD datasets; (2) apply these methods to reveal optimal treatment windows and target populations...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $344,164 project grant to Northwestern University to develop "M4: Modules on Advanced Methodology When Modeling Multinational Data." The primary objectives are to: 1) create a training program in large-scale data analysis for the next generation of researchers, 2) instruct trainees on protective behavioral and social factors related to Alzheimer's disease and related dementias...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $848,286 to the University of South Florida to conduct research on the role of N6-methyladenosine (m6A) RNA modifications in Alzheimer's disease (AD). The key objectives are to: 1) Create a high-resolution map of m6A sites in the brains of older adults, 2) Identify specific m6A alterations associated with AD and its clinical/pathological features, and 3) Elucidate how m6A dysregulation may...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $770,644 in funding to the University of Texas Health Science Center at San Antonio (UTHSCSA) to establish the Center for AD/ADRD Population Aging and Social Studies (CAPAS). The 6-year program aims to advance understanding of the unique aging experiences and Alzheimer's disease/related dementia (AD/ADRD) burden among the growing Hispanic/Latino older adult population in the U.S. Key focus areas include investigating socioeconomic, cultural, and life course factors contributing to AD/ADRD disparities, as well as developing interdisciplinary research expertise and improving dissemination of findings to stakeholders. The award started on September 1, 2025 and is set to conclude on August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $770.6k | 8/21/25 |